Biljana Stanković

Research Associate Professor
Laboratory for Molecular Biomedicine

Institute of Molecular Genetics and Genetic Engineering (IMGGE),
University of Belgrade (UB)

Vojvode Stepe 444a, PO box 23, 11010 Belgrade, Serbia
Mobile:    +381 65 397 64 45                            
Phone:    +381 11 397 64 45
Fax:        +381 11 397 58 08


2019-2021 Semi-master course „Bioinformatics for biologists“, The School of Computing, Union University, Belgrade, Serbia
2015 - PhD in Molecular Biology, Faculty of Biology (FB), University of Belgrade (UB)
(Thesis: „Molecular markers of chronic inflammation and apoptosis in inflammatory bowel diseases“)
2009 - Diploma (equivalent to M.Sc.) in Molecular biology and physiology, FB, UB


2021 - Research Associate Professor at Laboratory for Molecular Biomedicine, IMGGE
2016 - Research Associate at Laboratory for Molecular Biomedicine, IMGGE
2011 - Research Assistant at Laboratory for Molecular Biomedicine, IMGGE
2010 - Research Trainee at Laboratory for Molecular Hematology, IMGGE


National projects

  • 2020-2021 - Project „Nutrigenetics and status of vitamin D, zinc and selenium in Serbian population: are we ready for COVID-19?, financed by the „Pokreni se za nauku“ program - Participant
  • 2011-2019 - “Rare diseases: Molecular Pathophysiology, Diagnostic and Therapeutic Modalities and Social, Ethical and Legal Aspects”, No. 41004, Ministry of Education, Science and Technological Development, Republic of Serbia, working group “Crohn’s disease: molecular and genetic markers of altered inflammation and apoptosis and pharmacogenetic approach in modulation of therapy” - Participant
  • 2006–2010 –“Genomic elements in phenotype modulation”, No. 143051, Ministry of Science and Environmental Protection, Republic of Serbia - Participant

International projects

  • 2019-2023 CA18240 – “ADHEsion GPCR Network: Research and Implementation Set the path for future Exploration” - Management Committee member and Bioinformatics work package leader
  • 2020 – Winner of the Labena Grant Challenge - project „Towards personalized treatment for inflammatory bowel disease: pursuit for biomarkers of glucocorticoid drug response“– Leader
  • 2014-2015 – Serbia-Slovenia bilateral project “Pharmacogenomic markers in immunosuppressive and imunomodulatory therapy: from validated markers to genotyping kits and clinical algorithms”, 451-03-3095/2014-09/45 - Participant
  • Science in Motion for Friday Night Commotion “SCIMFONICOM” 2018-19 (H2020-MSCANIGHT-2018-818747) - Participant


  • 2020 – Volunteering in the National Laboratory for detection of infectious agents „Fire Eye“, Clinical Centre of Serbia
  • 2016-2020 – Teaching experience at postgraduate courses in Molecular biology at the Faculty of Biology, University of Belgrade: „Molecular genetics of human diseases “
  • 2018 – Member of the Local Organizing Committee of the 2nd Belgrade Bioinformatics Conference
  • 2011-2019 – Participant in numerous science popularization events (project “Little School of DNAlogy” and EU Researchers' Night)


Identification of molecular, pharmacogenomics and pharmacotranscriptomic markers associated with inflammatory bowel diseases (IBD), Crohn’s disease (CD) and ulcerative colitis (UC). Genetics of chronic inflammatory diseases induced by altered gut homeostasis. Pharmacogenomics and pharmacotranscriptomics of drugs used in treatment of pediatric acute lymphoblastic leukemia patients.

Applications of biostatistics and bioinformatics in biomedicine. Search for genetic risk factors of severe COVID-19. 


  1. Stankovic B, Dragasevic S, Klaassen K, Kotur N, Srzentic Drazilov S, Zukic B, Sokic Milutinovic A, Milovanovic T, Lukic S, Popovic D, Pavlovic S, Nikcevic G. Exploring inflammatory and apoptotic signatures in distinct Crohn's disease phenotypes: Way towards molecular stratification of patients and targeted therapy. Pathol Res Pract. 2020 Jun;216(6):152945.
  2. Stankovic B, Dragasevic S, Popovic D, Zukic B, Kotur N, Sokic-Milutinovic A, Alempijevic T, Lukic S, Milosavljevic T, Nikcevic G, Pavlovic S. Variations in inflammatory genes as molecular markers for prediction of inflammatory bowel disease occurrence. J Dig Dis. 2015 Dec; 16(12):723-33.
  3. Dragasevic S, Stankovic B, Sokic-Milutinovic A, Milosavljevic T, Milovanovic T, Lukic S, Drazilov SS, Klaassen K, Kotur N, Pavlovic S, Popovic D. Importance of TLR9-IL23-IL17 axis in inflammatory bowel disease development: Gene expression profiling study. Clin Immunol. 2018;197:86-95.
  4. Lucafò M, Stankovic B, Kotur N, Silvestre AD, Martelossi S, Ventura A, Zukic B, Pavlovic S, Decorti G. Pharmacotranscriptomic biomarkers in glucocorticoid treatment of pediatric inflammatory bowel disease. Curr Med Chem. 2018; 25(24):2855-2871.
  5. Bojović K, Stanković B, Kotur N, Krstić-Milošević D, Gašić V, Pavlović S, Zukić B, Ignjatović Đ. Genetic predictors of celiac disease, lactose intolerance, and vitamin D function and presence of peptide morphins in urine of children with neurodevelopmental disorders. Nutr Neurosci. 2019; 22(1):40-50.
  6. Marina Mihaljevic, Dusanka Franic, Ivan Soldatovic, Iva Lukic, Sanja Andric Petrovic, Tijana Mirjanic, Biljana Stankovic, Branka Zukic, Katarina Zeljic, Vladimir Gasic, Ivana Novakovic, Sonja Pavlovic, Miroslav Adzic, Nadja P. Maric. The FKBP5 genotype and childhood trauma effects on FKBP5 DNA methylation in patients with psychosis, their unaffected siblings, and healthy controls, Psychoneuroendocrinology, 2021, 105205.
  7. Dragasevic S, Stankovic B, Kotur N, Sokic-Milutinovic A, Milovanovic T, Lukic S, Milosavljevic T, Srzentic Drazilov S, Klaassen K, Pavlovic S, Popovic D. Metabolic Syndrome in Inflammatory Bowel Disease: Association with Genetic Markers of Obesity and Inflammation. Metab Syndr Relat Disord. 2020;18(1):31-38.
  8. Stanković B, Radlović N, Leković Z, Ristić D, Radlović V, Nikčević G, Kotur N, Vučićević K, Kostić T, Pavlović S, Zukic B. HLA genotyping in pediatric celiac disease patients. Bosn J Basic Med Sci. 2014 Aug 16; 14(3):171-6.
  9. Balasopoulou A, Stanković B, Panagiotara A, Nikčevic G, Peters BA, John A, Mendrinou E, Stratopoulos A, Legaki AI, Stathakopoulou V, Tsolia A, Govaris N, Govari S, Zagoriti Z, Poulas K, Kanariou M, Constantinidou N, Krini M, Spanou K, Radlovic N, Ali BR, Borg J, Drmanac R, Chrousos G, Pavlovic S, Roma E, Zukic B, Patrinos GP, Katsila T. Novel genetic risk variants for pediatric celiac disease. Hum Genomics. 2016 Oct 24; 10(1):34.
  10. Kotur N, Stankovic B, Kassela K, Georgitsi M, Vicha A, Leontari I, Dokmanovic L, Janic D, Krstovski N, Klaassen K, Radmilovic M, Stojiljkovic M, Nikcevic G, Simeonidis A, Sivolapenko G, Pavlovic S, Patrinos GP, Zukic B. 6-mercaptopurine influences TPMT gene transcription in a TPMT gene promoter variable number of tandem repeats-dependent manner. Pharmacogenomics. 2012; 13(3): 283-95.
  11. Kotur N, Dokmanovic L, Janic D, Stankovic B, Krstovski N, Tosic N, Katsila T, Patrinos GP, Zukic B, Pavlovic S. TPMT gene expression is increased during maintenance therapy in childhood acute lymphoblastic leukemia patients in a TPMT gene promoter variable number of tandem repeat-dependent manner. Pharmacogenomics. 2015; 16(15):1701-12.
  12. Kotur N, Lazic J, Ristivojevic B, Stankovic B, Gasic V, Dokmanovic L, Krstovski N, Milosevic G, Janic D, Zukic B, Pavlovic S. Pharmacogenomic Markers of Methotrexate Response in the Consolidation Phase of Pediatric Acute Lymphoblastic Leukemia Treatment. Genes (Basel). 2020 Apr 24;11(4):468.
  13. Pavlovic S, Kotur N, Stankovic B, Gasic V, Lucafo M, Decorti G, Zukic B. Clinical Application of Thiopurine Pharmacogenomics in Pediatrics. Curr Drug Metab. 2020;21(1):53-62.
  14. Pavlovic S, Kotur N, Stankovic B, Zukic B, Gasic V, Dokmanovic L. Pharmacogenomic and Pharmacotranscriptomic Profiling of Childhood Acute Lymphoblastic Leukemia: Paving the Way to Personalized Treatment. Genes (Basel). Genes (Basel). 2019;10(3):191.
  15. Klaassen K, Stankovic B, Zukic B, Kotur N, Gasic V, Pavlovic S, Stojiljkovic M. Functional prediction and comparative population analysis of variants in genes for proteases and innate immunity related to SARS-CoV-2 infection. Infect Genet Evol 2020; 84:104498.
  16. Stanković B, Kotur N, Gašić V, Klaassen K, Ristivojević B, Stojiljković M, Pavlović S, Zukić B. Pharmacogenomics landscape of COVID-19 therapy response in Serbian population and comparison with worldwide populations. J Med Biochem. 2020 Oct 2;39(4):488-499.

Please publish modules in offcanvas position.